LANCET, cilt.396, sa.10252, ss.684-692, 2020 (SCI-Expanded)
Background There are no effective therapies for achondroplasia. An open-label study suggested that vosoritide administration might increase growth velocity in children with achondroplasia. This phase 3 trial was designed to further assess these preliminary findings.